Xtant Medical Holdings, Inc. (XTNT) News

Xtant Medical Holdings, Inc. (XTNT): $0.48

0.01 (+2.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter XTNT News Items

XTNT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest XTNT News From Around the Web

Below are the latest news stories about Xtant Medical Holdings Inc that investors may wish to consider to help them evaluate XTNT as an investment opportunity.

Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference

BELGRADE, Mont., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com, beginning on

Yahoo | January 4, 2022

Xtant Medical Appoints Scott Neils Interim Chief Financial Officer

BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Company’s current Vice President, Finance and Chief Financial Officer, effective January 3, 2022. “We are excited to announce this well deserved promotion for Scott. His demonstrated

Yahoo | January 3, 2022

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 197,600 shares, a decrease of 21.7% from the October 31st total of 252,500 shares. Based on an average daily volume of 140,900 shares, the days-to-cover ratio []

Dakota Financial News | December 5, 2021

Xtant Medical Holdings'' (XTNT) CEO Sean Browne on Q3 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | November 12, 2021

Xtant Medical Announces Third Quarter 2021 Financial Results

BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2021.

Intrado Digital Media | November 12, 2021

Xtant Medical to Issue Third Quarter 2021 Financial Results on November 12, 2021

BELGRADE, Mont., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2021, before the open of the financial markets on Friday, November 12, 2021. Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial O

Yahoo | November 5, 2021

Xtant Medical Honors Donor Hero on the Donate Life Rose Parade® Float

Company Among Sponsors of Donate Life Float at 2022 Rose Parade Samuel Lee Becker Samuel Lee Becker BELGRADE, Mont., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, honors Samuel Lee Becker, a donor hero, as part of its sponsorship of the 2022 Donate Life Float at the Rose Parade in Pasadena on New Year’s Day. Sam was forever a giver who gave freely and f

Yahoo | October 19, 2021

Xtant Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BELGRADE, Mont., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13 - 15, 2021. A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com

Yahoo | September 7, 2021

Xtant Medical Announces Second Quarter 2021 Financial Results

BELGRADE, Mont., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2021. Second Quarter 2021 Financial Highlights: Revenue for the second quarter of 2021 totaled $15.0 million, an increase of 42% over the prior-year periodGross margin in the second quarter of 2021 was 63.5%

Yahoo | August 5, 2021

Xtant Medical to Issue Second Quarter 2021 Financial Results on August 5, 2021

BELGRADE, Mont., July 29, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2021, before the open of the financial markets on Thursday, August 5, 2021. Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Office

Yahoo | July 29, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.462 seconds.